Strong private equity investment and strategic M&A in 2024, and a shift toward clinical-stage companies and asset-driven strategies, have set the healthcare and biotech industries on a positive trajectory for 2025, writes Joseph Pategou.
Investing in employee training and development is not just beneficial for the employees. It also contributes significantly to the organization’s success and competitive advantage.
This insightful roundtable discussion delves into the findings from Greenphire’s 2024 Market Trends Survey. Experts uncover the key challenges and priorities shaping clinical trials in 2025.
Dysphagia impacts treatment compliance and disproportionately affects the elderly. Learn how microencapsulation enabled formulation of a water-soluble powder drives patient adherence.
This website uses cookies to ensure you get the best experience on our website. Learn more
